Health, Fitness & Food

Defense attorney Larry Ottaway speaks during opening arguments on the first day of a trial of Johnson & Johnson over claims they engaged in deceptive marketing that contributed to the national opioid epidemic in Norman, Oklahoma, U.S. May 28, 2019. Sue Ogrocki | Reuters An Oklahoma judge Monday approved Teva Pharmaceuticals‘ revised $85 million settlement
0 Comments
Image Source | Getty Images Dietary advice seems to change every decade. Fat is bad, then suddenly it’s good again. Nowadays, for many people, carbs are the enemy. But it turns out that healthy dietary guidelines can’t be boiled down into simple rules. A new crop of studies, which leverage the latest health testing and
0 Comments
Peter Hames Big Health CEO Peter Hames wants people to use his app to treat their insomnia — and then delete it for good. His app, Sleepio, essentially works by leveraging an approach known as cognitive behavioral therapy, which aims to give users the tools to manage their own thought patterns differently and overcome their anxieties.
0 Comments
Nick Leschly, CEO of Bluebird Bio in Cambridge. Wendy Maeda | The Boston Globe | Getty Images Bluebird Bio CEO Nick Leschly on Friday defended the biotech company’s $1.8 million price tag for its new gene therapy to treat a rare genetic blood disorder. Bluebird’s therapy, Zynteglo, was approved in Europe earlier this month for
0 Comments
Zoe Barry, CEO and co-founder, ZappRx Source: Zoe Barry Medical software company Allscripts has bought ZappRx, a start-up that aimed to modernize how people access prescription medicines, say two people familiar with the deal, the company confirmed on Thursday. ZappRx raised more than $40 million from investors ranging from GV, Alphabet‘s early-stage venture arm, and
0 Comments
Bernard Charles, chief executive officer of Dassault Systemes SA. Simon Dawson | Bloomberg | Getty Images French technology company Dassault Systèmes is nearing a deal to acquire Medidata Solutions, according to people familiar with the matter. The likely agreement was reported earlier by Bloomberg, which also published a story in April saying the companies were in
0 Comments
Maria Alessio, left, retired from Walgreens in fall of 2018 expecting the drugstore chain to help her pay for health insurance. Walgreens cut the payments for her and about 550 other early retirees shortly after Alessio retired. Source: Maria Alessio Maria Alessio loved working for Walgreens Boots Alliance, especially because of the pharmacy chain’s benefits.
0 Comments
A promotional person vaping. John Keeble | Getty Images U.S. regulators slapped four e-cigarette companies with warning letters Friday for failing to follow federal advertising rules for tobacco on Instagram, Facebook and Twitter. The Food and Drug Administration and Federal Trade Commission reprimanded Solace Technologies, Hype City Vapors, Humble Juice Co. and Artist Liquids Laboratories for
0 Comments
Tim Cook, chief executive officer of Apple Inc., speaks during the Apple Inc. Spring Forward event in San Francisco, California. David Paul Morris | Bloomberg | Getty Images Apple unveiled menstrual cycle tracking and health hearing apps, among other health-related updates, at the company’s annual developers conference on Monday. Called “cycle tracking,” women can log
0 Comments
Martin Shkreli, former chief executive officer of Turing Pharmaceuticals AG, arrives at federal court in the Brooklyn borough of New York, on Monday, July 31, 2017. Peter Foley | Bloomberg | Getty Images Notorious ‘pharma bro’ Martin Shkreli on Friday sued two directors and the ex-general counsel of his former biopharmaceutical company Retrophin, accusing them
0 Comments
Vascepa Source: Amarin Amarin shares surged 15% in early afternoon trading Wednesday after the biopharmaceutical company said the Food and Drug Administration agreed to an expedited review of its prescription-strength fish oil pill for patients at risk of heart attack or strokes. The FDA will grant priority review for Amarin’s heart drug derived from fish
0 Comments